ArticleFrontiers in microbiology2022

Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and

Rajkumar Kulandaisamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.